The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study. [electronic resource]
Producer: 20060126Description: 677-86 p. digitalISSN:- 0300-0605
- Aged
- Albuminuria -- diagnosis
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Benzimidazoles -- pharmacology
- Benzoates -- pharmacology
- Blood Pressure
- Creatinine -- blood
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Nephropathies -- drug therapy
- Female
- Humans
- Kidney -- drug effects
- Kidney Diseases -- prevention & control
- Male
- Middle Aged
- Reference Values
- Telmisartan
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.